Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.62, a high estimate of $8.00, ...

Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...

ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors ORIC-944 is a ...

VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...

Looking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...

Enzymes, the core catalysts in life, drive critical biological processes ranging from metabolic regulation to energy ...

Oncogenic proteins are essential for the development and spread of tumors, making cancer a significant worldwide health ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Neighbors around Griffith Road in Winston-Salem are opposing the plan to remake Myers Grocery Store, once a small, longtime ...